Clinical characteristics of hemophagocytic lymphohistiocytosis following kawasaki disease: Differentiation from recurrent kawasaki disease

Blood Research

Volumn 48, Issue 4, 2013, Pages 254-257

  Kang, Hae Ryong ^a   Kwon, Yong hoon ^a   Yoo, Eun Sun ^b   Ryu, Kyung Ha ^b   Kim, Ji Yoon ^c   Kim, Heung Sik ^c   Kim, Hwang Min ^d   Lee, Young Ho ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Dongsan Medical Center   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Hemophagocytic lymphohistiocytosis; Kawasaki disease; Recurrent

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HUMAN; MALE; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; OVERALL SURVIVAL; PRESCHOOL CHILD; RECURRENT DISEASE; RECURRENT FEVER; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 84891044857     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2013.48.4.254     Document Type: Article

References (22)

1. Palazzi D, McClain K, Kaplan S. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003;22:663-6.
2. Grom A. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003;15:587-90.
3. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
4. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
5. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics 2003;112:e495.
6. Al-Eid W, Al-Jefri A, Bahabri S, Al-Mayouf S. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000;17:323-9.
7. Kaneko K, Takahashi K, Fujiwara S, Maluynma T, Obinata K. Kawasaki disease followed by hemophagocytic syndrome. Eur J Pediatr 1998;157:610-1.
8. Ohga S, Ooshima A, Fukushige A, Ueda K. Histiocytic hemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995;154:539-41.
9. Cummings C, McCarthy P, van Hoff J, Porter G. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 2008;27:1116-8.
10. Titze U, Janka G, Schneider EM, Prall F, Haffner D, Classen CF. Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer 2009;53:493-5.
11. Kim HK, Kim HG, Cho SJ, et al. Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease. Pediatr Hematol Oncol 2011;28:230-6.
12. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005;24:998-1004.
13. Asano T, Sudoh M, Watanabe M, Fujino O. Transient thrombocytopenia with large platelets in Kawasaki disease. Pediatr Hematol Oncol 2007;24:551-4.
14. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009:127-31.
15. Kim SY, Yoon JY, Lee SJ, et al. The clinical manifestations of hemophagocytic lymphohistiocytosis. Korean J Pediatr Hematol Oncol 2003;10:244-54.
16. Park YW. Epidemiology of Kawasaki disease in Korea. Korean J Pediatr 2008;51:452-6.
17. Lee HJ, Cho AR, Kim HS, Sohn S. Clinical Characteristics of recurrent Kawasaki disease. Korean J Pediatr 2004;47:879-83.
18. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis. J Pediatr 1996;129:750-4.
19. Kim KJ, Kim KH, Lee TJ, Chun JK, Lyu CJ, Kim DS. Clinical characteristics and prognostic factors for survival in hemophagocytic lymphohistiocytosis. Korean J Pediatr 2008;51:299-306.
20. Park HS, Kim DY, Lee JH, et al. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic fact. Ann Hematol 2012;91:897-904.
21. Im HJ, Song JS, Bae KU, et al. Outcome of hemophagocytic lymphohistiocytosis treated with HLH-94/2004 in Korea. The 32nd world congress of the international society of hematology 2008;64:abst 127.
22. Yoon HS, Kim HJ, Yoo KH, et al. The UNC13D gene is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Haematologica 2010;95:622-6.